Genome-Centric Multimodal Data Integration in Personalised Cardiovascular Medicine.

News

The NextGen Project is organising a roundtable discussion during the DIA Europe 2025 annual meeting to explore and assess genomic penetrance to diversity and bias in datasets. DIA is the Drug Information Organisation operating globally. The Roundtable exercise will explore key issues related to penetrance and disease expression, particularly how the composition of individuals enrolled […]

Our NextGen project is actively participating in the DIA Europe 2025 annual meeting, taking place from 18 to 20 March 2025 in Basel, Switzerland. DIA Global – Drug Information Organisation is partner in the NextGen project and the leading global multidisciplinary life science membership association, which drives collaboration in drug, device, and diagnostic development in pursuit of a healthier world. […]

During the ESC Congress 2024 in London, we had the pleasure to record a video with Saskia Haitjema, from UMC Utrecht, interviewed by Imo Hofer.Saskia, who is a Principal Investigator of the articulate NextGen project, provides an excellent overview of NextGen scope and strategy, of the general and specific objectives, with highlights on the new […]

Sophia Antipolis, 12 February 2024:  An innovative project using artificial intelligence (AI) to personalise therapies for patients with cardiovascular disease has kicked off at a meeting in Utrecht, the Netherlands.

The NextGen project has received €7.6 million from the EU’s Horizon Europe programme, a €3.1 million grant by the Swiss State Secretariat for Education, Research and Innovation (SERI), as well as the UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee. NextGen will be delivered by a 21-member consortium, including the European Society of Cardiology (ESC).1